A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis

Clinical trial NCT07321093 · RECRUITING

Trial details

NCT number: NCT07321093
Sponsor: Biocad
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing-remitting Multiple Sclerosis (RRMS)

Start date: 2025-11-01
Primary completion: 2028-12-01
Enrollment: 292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.